According to DataM Intelligence, the global Lung Cancer Treatment Market was valued at approximately USD 32.64 billion in 2024 and is projected to reach USD 73.29 billion by 2033, growing at a compound annual growth rate (CAGR) of 9.5% during the forecast period from 2025 to 2033. The market expansion is driven by the rising incidence of lung cancer, increasing adoption of advanced...